{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T03:37:35Z","timestamp":1764733055008,"version":"3.37.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012957","name":"Friedrich-Schiller-Universit\u00e4t Jena","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012957","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:sec>\n                <jats:title>Hintergrund<\/jats:title>\n                <jats:p>Die St\u00e4ndige Impfkommission empfiehlt eine j\u00e4hrliche Influenzaimpfung als Standardimpfung f\u00fcr \u2265\u202f60-J\u00e4hrige und als altersunabh\u00e4ngige Indikationsimpfung. Empirische Daten zur wiederholten Impfung liegen f\u00fcr Deutschland nicht vor. Ziel der Studie war es daher, H\u00e4ufigkeit und Einflussfaktoren der wiederholten Impfung zu untersuchen.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methoden<\/jats:title>\n                <jats:p>Wir f\u00fchrten eine l\u00e4ngsschnittliche retrospektive Beobachtungsstudie mit Routinedaten von \u2265\u202f60\u2011j\u00e4hrigen Versicherten der Th\u00fcringer AOK Plus im Zeitraum 2012\u20132018 durch. Die Anzahl der Saisons mit Impfung wurde beschrieben und der Zusammenhang mit verschiedenen Versichertenmerkmalen in einem Regressionsmodell analysiert.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Ergebnisse<\/jats:title>\n                <jats:p>Es wurden 103.163 Versicherte mit mindestens einer Impfung in der Saison 2014\/2015 eingeschlossen, von denen 75,3\u202f% in \u2265\u202f6 von 7\u00a0Saisons geimpft wurden. H\u00e4ufigere Impfungen zeigten sich bei Pflegeheimbewohner:innen (Rate Ratio (RR) 1,27), Personen mit erh\u00f6hter gesundheitlicher Gef\u00e4hrdung infolge einer Grunderkrankung (RR 1,21) und h\u00f6heren Altersgruppen (vs. 60- bis 69-J\u00e4hrige: RR 1,17\u20131,25). Mit jedem zus\u00e4tzlichen Jahr der Teilnahme an einem Disease-Management-Programm stieg die Anzahl der Impfungen (RR 1,03). Weniger h\u00e4ufig geimpft waren Frauen (RR 0,91), Versicherte mit Pflegestufe\u00a01 (vs. keiner Pflegestufe: RR 0,90) und Versicherte mit einer Komorbidit\u00e4t (vs. keiner Komorbidit\u00e4t: RR 0,97).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Diskussion<\/jats:title>\n                <jats:p>Ein Gro\u00dfteil der einmal gegen Influenza geimpften \u2265\u202f60-J\u00e4hrigen l\u00e4sst sich auch wiederholt impfen. Entsprechend den Empfehlungen sind vor allem Pflegeheimbewohner:innen und Personen mit erh\u00f6hter gesundheitlicher Gef\u00e4hrdung wiederholt geimpft. Haus\u00e4rzt:innen kommt eine zentrale Rolle zu: Nichtakute Patientenkontakte sollten f\u00fcr Impfangebote genutzt werden, insbesondere bei Frauen und in der H\u00e4uslichkeit lebenden Pflegebed\u00fcrftigen.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00103-023-03716-1","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T17:01:36Z","timestamp":1686243696000},"page":"953-961","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Einmal geimpft, immer geimpft? Routinedatenanalyse zur wiederholten Influenzaimpfung von \u2265\u202f60-J\u00e4hrigen","Once vaccinated, always vaccinated? A\u00a0claims data analysis on repeated influenza vaccinations among individuals aged \u2265\u202f60\u00a0years"],"prefix":"10.1007","volume":"66","author":[{"given":"Josephine","family":"Storch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska","family":"Meissner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique","family":"B\u00f6de","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Kwetkat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias W.","family":"Pletz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antje","family":"Freytag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"key":"3716_CR1","volume-title":"Bericht zur Epidemiologie der Influenza in Deutschland. Saison 2013\/14","author":"Robert Koch-Institut","year":"2014","unstructured":"Robert Koch-Institut (2014) Bericht zur Epidemiologie der Influenza in Deutschland. Saison 2013\/14. Robert Koch-Institut, Berlin"},{"key":"3716_CR2","volume-title":"Bericht zur Epidemiologie der Influenza in Deutschland. Saison 2017\/18","author":"Robert Koch-Institut","year":"2018","unstructured":"Robert Koch-Institut (2018) Bericht zur Epidemiologie der Influenza in Deutschland. Saison 2017\/18. Robert Koch-Institut, Berlin"},{"key":"3716_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1086\/515616","volume":"178","author":"L Simonsen","year":"1998","unstructured":"Simonsen\u00a0L, Clarke\u00a0MJ, Schonberger\u00a0LB, Arden\u00a0NH, Cox\u00a0NJ, Fukuda\u00a0K (1998) Pandemic versus epidemic influenza mortality: a\u00a0pattern of changing age distribution. J\u00a0Infect Dis 178:53\u201360. https:\/\/doi.org\/10.1086\/515616","journal-title":"J Infect Dis"},{"key":"3716_CR4","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1007\/s00103-016-2467-8","volume":"59","author":"C Remschmidt","year":"2016","unstructured":"Remschmidt\u00a0C, Harder\u00a0T, Wichmann\u00a0O et\u00a0al (2016) Hintergrundpapier der STIKO: Evaluation der bestehenden Influenzaimpfempfehlung f\u00fcr Indikationsgruppen und f\u00fcr Senioren (Standardimpfung ab 60\u00a0Jahren). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 59:1606\u20131622. https:\/\/doi.org\/10.1007\/s00103-016-2467-8","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"3716_CR5","volume-title":"Bericht zur Epidemiologie der Influenza in Deutschland. Saison 2014\/15","author":"Robert Koch-Institut","year":"2015","unstructured":"Robert Koch-Institut (2015) Bericht zur Epidemiologie der Influenza in Deutschland. Saison 2014\/15. Robert Koch-Institut, Berlin"},{"key":"3716_CR6","volume-title":"Bericht zur Epidemiologie der Influenza in Deutschland. Saison 2016\/17","author":"Robert Koch-Institut","year":"2017","unstructured":"Robert Koch-Institut (2017) Bericht zur Epidemiologie der Influenza in Deutschland. Saison 2016\/17. Robert Koch-Institut, Berlin"},{"key":"3716_CR7","first-page":"283","volume":"30","author":"Robert Koch-Institut","year":"2012","unstructured":"Robert Koch-Institut (2012) Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut\/ Stand: Juli 2012. Epidemiol Bull 30:283\u2013310","journal-title":"Epidemiol Bull"},{"key":"3716_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.17886\/EpiBull-2016-001","volume":"01","author":"Robert Koch-Institut","year":"2016","unstructured":"Robert Koch-Institut (2016) Aktuelles aus der KV-Impfsurveillance: Impfquoten der Masern\u2011, HPV- und Influenza-Impfung in Deutschland. Epidemiol Bull 01:1\u201310. https:\/\/doi.org\/10.17886\/EpiBull-2016-001","journal-title":"Epidemiol Bull"},{"key":"3716_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-0882-3","author":"C Remschmidt","year":"2015","unstructured":"Remschmidt\u00a0C, Rieck\u00a0T, B\u00f6deker\u00a0B, Wichmann\u00a0O (2015) Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany. BMC Infect Dis. https:\/\/doi.org\/10.1186\/s12879-015-0882-3","journal-title":"BMC Infect Dis"},{"key":"3716_CR10","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1016\/j.amepre.2020.05.009","volume":"59","author":"BH Bardenheier","year":"2020","unstructured":"Bardenheier\u00a0BH, Zullo\u00a0AR, Jutkowitz\u00a0E, Gravenstein\u00a0S (2020) Characteristics of repeated influenza vaccination among older U.S. adults. Am J Prev Med 59:e179\u2013e188. https:\/\/doi.org\/10.1016\/j.amepre.2020.05.009","journal-title":"Am J Prev Med"},{"key":"3716_CR11","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1093\/cid\/ciu680","volume":"59","author":"HQ McLean","year":"2014","unstructured":"McLean\u00a0HQ, Thompson\u00a0MG, Sundaram\u00a0ME et\u00a0al (2014) Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons. Clin Infect Dis 59:1375\u20131385. https:\/\/doi.org\/10.1093\/cid\/ciu680","journal-title":"Clin Infect Dis"},{"key":"3716_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2147\/CIA.S238786","volume":"15","author":"P-S Hsu","year":"2020","unstructured":"Hsu\u00a0P\u2011S, Lian\u00a0I\u2011B, Chao\u00a0D\u2011Y (2020) A population-based propensity score-matched study to assess the impact of repeated vaccination on vaccine effectiveness for influenza-associated hospitalization among the elderly. Clin Interv Aging 15:301\u2013312. https:\/\/doi.org\/10.2147\/CIA.S238786","journal-title":"Clin Interv Aging"},{"key":"3716_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14760584.2017.1334554","volume":"16","author":"EA Belongia","year":"2017","unstructured":"Belongia\u00a0EA, Skowronski\u00a0DM, McLean\u00a0HQ, Chambers\u00a0C, Sundaram\u00a0ME, De Serres\u00a0G (2017) Repeated annual influenza vaccination and vaccine effectiveness: review of evidence. Expert Rev Vaccines 16:1\u201314. https:\/\/doi.org\/10.1080\/14760584.2017.1334554","journal-title":"Expert Rev Vaccines"},{"key":"3716_CR14","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3238\/arztebl.2010.0845","volume":"107","author":"AM Reuss","year":"2010","unstructured":"Reuss\u00a0AM, Walter\u00a0D, Feig\u00a0M et\u00a0al (2010) Influenza vaccination coverage in the 2004\/05, 2005\/06, and 2006\/07 seasons: a\u00a0secondary data analysis based on billing data of the German associations of statutory health insurance physicians. Dtsch Arztebl Int 107:845\u2013850. https:\/\/doi.org\/10.3238\/arztebl.2010.0845","journal-title":"Dtsch Arztebl Int"},{"key":"3716_CR15","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1186\/s12889-018-5787-9","volume":"18","author":"C Betsch","year":"2018","unstructured":"Betsch\u00a0C, Rossmann\u00a0C, Pletz\u00a0MW et al (2018) Increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60. BMC Public Health 18:885. https:\/\/doi.org\/10.1186\/s12889-018-5787-9","journal-title":"BMC Public Health"},{"key":"3716_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10198-021-01343-8","volume":"23","author":"J Storch","year":"2021","unstructured":"Storch\u00a0J, Fleischmann-Struzek\u00a0C, Rose\u00a0N et al (2021) The effect of influenza and pneumococcal vaccination in the elderly on health service utilisation and costs: a\u00a0claims data-based cohort study. Eur J Health Econ 23:67\u201380. https:\/\/doi.org\/10.1007\/s10198-021-01343-8","journal-title":"Eur J Health Econ"},{"key":"3716_CR17","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1845525","author":"N Rose","year":"2021","unstructured":"Rose\u00a0N, Storch\u00a0J, Mikolajetz\u00a0A et al (2021) Preventive effects of influenza and pneumococcal vaccination in the elderly\u2014results from a\u00a0population-based retrospective cohort study. Hum Vaccin Immunother. https:\/\/doi.org\/10.1080\/21645515.2020.1845525","journal-title":"Hum Vaccin Immunother"},{"key":"3716_CR18","unstructured":"Plus AOK (2022) Strukturdaten der AOK Plus. https:\/\/www.aok.de\/pk\/magazin\/cms\/fileadmin\/pk\/plus\/pdf\/strukturdaten-langversion-aokplus.pdf. Zugegriffen: 18. Aug. 2022"},{"key":"3716_CR19","doi-asserted-by":"publisher","first-page":"e145","DOI":"10.1055\/s-0042-108647","volume":"78","author":"E Swart","year":"2016","unstructured":"Swart\u00a0E, Bitzer\u00a0EM, Gothe\u00a0H et\u00a0al (2016) STandardisierte BerichtsROutine f\u00fcr Sekund\u00e4rdaten Analysen (STROSA) \u2013 ein konsentierter Berichtsstandard f\u00fcr Deutschland, Version 2. Gesundheitswesen 78:e145\u2013e160. https:\/\/doi.org\/10.1055\/s-0042-108647","journal-title":"Gesundheitswesen"},{"key":"3716_CR20","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1007\/s40520-019-01367-4","volume":"32","author":"I Dardalas","year":"2020","unstructured":"Dardalas\u00a0I, Pourzitaki\u00a0C, Manomenidis\u00a0G et al (2020) Predictors of influenza vaccination among elderly: a\u00a0cross-sectional survey in Greece. Aging Clin Exp Res 32:1821\u20131828. https:\/\/doi.org\/10.1007\/s40520-019-01367-4","journal-title":"Aging Clin Exp Res"},{"key":"3716_CR21","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1186\/s12889-015-1970-4","volume":"15","author":"B B\u00f6deker","year":"2015","unstructured":"B\u00f6deker\u00a0B, Remschmidt\u00a0C, Schmich\u00a0P, Wichmann\u00a0O (2015) Why are older adults and individuals with underlying chronic diseases in Germany not vaccinated against flu? A population-based study. BMC Public Health 15:618. https:\/\/doi.org\/10.1186\/s12889-015-1970-4","journal-title":"BMC Public Health"},{"key":"3716_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s00103-018-2854-4","volume":"62","author":"D Kurch-Bek","year":"2019","unstructured":"Kurch-Bek\u00a0D, Gallowitz\u00a0C, Tenckhoff\u00a0B, Sundmacher\u00a0L (2019) Influenza vaccination rates before and after admission to nursing homes in Germany (Influenza vaccination rates of patients with statutory ambulatory medical care in protective facilities and in nursing and special care homes). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 62:84\u201393. https:\/\/doi.org\/10.1007\/s00103-018-2854-4","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"3716_CR23","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s40520-017-0825-5","volume":"30","author":"O Spreckelsen","year":"2018","unstructured":"Spreckelsen\u00a0O, Luque Ramos\u00a0A, Freitag\u00a0M, Hoffmann\u00a0F (2018) Influenza vaccination rates before and after admission to nursing homes in Germany. Aging Clin Exp Res 30:609\u2013616. https:\/\/doi.org\/10.1007\/s40520-017-0825-5","journal-title":"Aging Clin Exp Res"},{"key":"3716_CR24","first-page":"305","volume":"34","author":"Robert Koch-Institut","year":"2014","unstructured":"Robert Koch-Institut (2014) Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut\/Stand: August 2014. Epidemiol Bull 34:305\u2013340","journal-title":"Epidemiol Bull"},{"key":"3716_CR25","doi-asserted-by":"publisher","first-page":"e0194371","DOI":"10.1371\/journal.pone.0194371","volume":"13","author":"D Schwarzkopf","year":"2018","unstructured":"Schwarzkopf\u00a0D, Fleischmann-Struzek\u00a0C, R\u00fcddel\u00a0H, Reinhart\u00a0K, Thomas-R\u00fcddel\u00a0DO (2018) A risk-model for hospital mortality among patients with severe sepsis or septic shock based on German national administrative claims data. PLoS ONE 13:e194371. https:\/\/doi.org\/10.1371\/journal.pone.0194371","journal-title":"PLoS ONE"},{"key":"3716_CR26","first-page":"195","volume":"97","author":"OA Sawicki","year":"2021","unstructured":"Sawicki\u00a0OA, M\u00fcller\u00a0A, Glushan\u00a0A et al (2021) Influenza-Impfrate in der \u00e4lteren Bev\u00f6lkerung in und au\u00dferhalb der HZV in Baden-W\u00fcrttemberg. ZFA Online 97:195\u2013199. https:\/\/doi.org\/10.3238\/zfa.2021.0195\u20130199","journal-title":"ZFA Online"},{"key":"3716_CR27","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1017\/S095026880200780X","volume":"129","author":"B Christenson","year":"2002","unstructured":"Christenson\u00a0B, Lundbergh\u00a0P (2002) Comparison between cohorts vaccinated and unvaccinated against influenza and pneumococcal infection. Epidemiol Infect 129:515\u2013524. https:\/\/doi.org\/10.1017\/S095026880200780X","journal-title":"Epidemiol Infect"},{"key":"3716_CR28","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.4161\/hv.7.12.18130","volume":"7","author":"MM B\u00f6hmer","year":"2011","unstructured":"B\u00f6hmer\u00a0MM, Walter\u00a0D, Krause\u00a0G, M\u00fcters\u00a0S, G\u00f6sswald\u00a0A, Wichmann\u00a0O (2011) Determinants of tetanus and seasonal influenza vaccine uptake in adults living in Germany. Hum Vaccin 7:1317\u20131325. https:\/\/doi.org\/10.4161\/hv.7.12.18130","journal-title":"Hum Vaccin"},{"key":"3716_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7101a1","volume":"71","author":"LA Grohskopf","year":"2022","unstructured":"Grohskopf\u00a0LA, Blanton\u00a0LH, Ferdinands\u00a0JM et\u00a0al (2022) Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices\u2014United States, 2022\u201323 influenza season. MMWR Recomm Rep 71:1\u201328. https:\/\/doi.org\/10.15585\/mmwr.rr7101a1","journal-title":"MMWR Recomm Rep"},{"key":"3716_CR30","doi-asserted-by":"publisher","DOI":"10.20364\/VA-12.03","volume-title":"Influenza-Impfraten bei Patienten \u00fcber 60\u00a0Jahre \u2013 Basisbericht 2007\/2008","author":"B Riens","year":"2012","unstructured":"Riens\u00a0B, Mangiapane\u00a0S, Erhart\u00a0M, von Stillfried\u00a0D (2012) Influenza-Impfraten bei Patienten \u00fcber 60\u00a0Jahre \u2013 Basisbericht 2007\/2008 https:\/\/doi.org\/10.20364\/VA-12.03 (Versorgungsatlas-Bericht)"},{"key":"3716_CR31","doi-asserted-by":"publisher","DOI":"10.20364\/VA-13.02","volume-title":"Influenza-Impfraten bei Patienten \u00fcber 60\u00a0Jahre \u2013 Update 2009\/2010","author":"B Riens","year":"2013","unstructured":"Riens\u00a0B, Mangiapane\u00a0S (2013) Influenza-Impfraten bei Patienten \u00fcber 60\u00a0Jahre \u2013 Update 2009\/2010 https:\/\/doi.org\/10.20364\/VA-13.02 (Versorgungsatlas-Bericht)"},{"key":"3716_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.25646\/7658","volume":"47","author":"T Rieck","year":"2020","unstructured":"Rieck\u00a0T, Steffen\u00a0A, Schmid-K\u00fcpke\u00a0N, Feig\u00a0M, Wichmann\u00a0O, Siedler\u00a0A (2020) Impfquoten bei Erwachsenen in Deutschland \u2013 Aktuelles aus der KV-Impfsurveillance und der Onlinebefragung von Krankenhauspersonal OKaPII. Epidemiol Bull 47:3\u201326. https:\/\/doi.org\/10.25646\/7658","journal-title":"Epidemiol Bull"},{"key":"3716_CR33","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s00391-015-0926-8","volume":"49","author":"A Kwetkat","year":"2016","unstructured":"Kwetkat\u00a0A, Lehmann\u00a0T, Weinberger\u00a0S, Schelling\u00a0J (2016) Analyse der Impfdaten von 60-J\u00e4hrigen und \u00c4lteren aus Bayern und Th\u00fcringen. Z\u00a0Gerontol Geriatr 49:126\u2013131. https:\/\/doi.org\/10.1007\/s00391-015-0926-8","journal-title":"Z Gerontol Geriatr"},{"key":"3716_CR34","doi-asserted-by":"publisher","first-page":"7095","DOI":"10.1016\/j.vaccine.2017.10.086","volume":"35","author":"C Dios-Guerra","year":"2017","unstructured":"Dios-Guerra\u00a0C, Carmona-Torres\u00a0JM, L\u00f3pez-Soto\u00a0PJ, Morales-Can\u00e9\u00a0I, Rodr\u00edguez-Borrego\u00a0MA (2017) Prevalence and factors associated with influenza vaccination of persons over 65\u00a0years old in Spain (2009\u20132014). Vaccine 35:7095\u20137100. https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.086","journal-title":"Vaccine"},{"key":"3716_CR35","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.vaccine.2020.12.081","volume":"39","author":"MK Akmatov","year":"2021","unstructured":"Akmatov\u00a0MK, Holstiege\u00a0J, Steffen\u00a0A, B\u00e4tzing\u00a0J (2021) Utilization of influenza vaccination among chronically ill individuals in Germany: a nationwide claims-based analysis. Vaccine 39:952\u2013960. https:\/\/doi.org\/10.1016\/j.vaccine.2020.12.081","journal-title":"Vaccine"},{"key":"3716_CR36","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.jclinepi.2008.06.014","volume":"62","author":"JC Nelson","year":"2009","unstructured":"Nelson\u00a0JC, Jackson\u00a0ML, Weiss\u00a0NS, Jackson\u00a0LA (2009) New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J\u00a0Clin Epidemiol 62:687\u2013694. https:\/\/doi.org\/10.1016\/j.jclinepi.2008.06.014","journal-title":"J Clin Epidemiol"},{"key":"3716_CR37","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s11606-010-1609-1","volume":"26","author":"WH Shrank","year":"2011","unstructured":"Shrank\u00a0WH, Patrick\u00a0AR, Brookhart\u00a0MA (2011) Healthy user and related biases in observational studies of preventive interventions: a\u00a0primer for physicians. J\u00a0Gen Intern Med 26:546\u2013550. https:\/\/doi.org\/10.1007\/s11606-010-1609-1","journal-title":"J Gen Intern Med"},{"key":"3716_CR38","doi-asserted-by":"publisher","DOI":"10.25646\/8824","author":"Robert Koch-Institut","year":"2021","unstructured":"Robert Koch-Institut (2021) Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) beim Robert Koch-Institut 2021. Epidemiol Bull. https:\/\/doi.org\/10.25646\/8824","journal-title":"Epidemiol Bull"},{"key":"3716_CR39","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00103-014-2044-y","volume":"57","author":"B B\u00f6deker","year":"2014","unstructured":"B\u00f6deker\u00a0B, Wichmann\u00a0O, Mertens\u00a0B, Seefeld\u00a0L, Pott\u00a0E (2014) Umsetzung der Influenzaimpfempfehlung in Alten- und Pflegeheimen : Ergebnisse einer Erhebung im Rahmen der nationalen Influenza-Impfaufkl\u00e4rungskampagne. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 57:1315\u20131321. https:\/\/doi.org\/10.1007\/s00103-014-2044-y","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"3716_CR40","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s12879-015-1154-y","volume":"15","author":"C Remschmidt","year":"2015","unstructured":"Remschmidt\u00a0C, Wichmann\u00a0O, Harder\u00a0T (2015) Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a\u00a0systematic review. BMC Infect Dis 15:429. https:\/\/doi.org\/10.1186\/s12879-015-1154-y","journal-title":"BMC Infect Dis"},{"key":"3716_CR41","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s00103-019-02900-6","volume":"62","author":"C Betsch","year":"2019","unstructured":"Betsch\u00a0C, Schmid\u00a0P, Korn\u00a0L et\u00a0al (2019) Impfverhalten psychologisch erkl\u00e4ren, messen und ver\u00e4ndern [Psychological antecedents of vaccination: definitions, measurement, and interventions]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 62:400\u2013409. https:\/\/doi.org\/10.1007\/s00103-019-02900-6","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"3716_CR42","doi-asserted-by":"publisher","first-page":"e0208601","DOI":"10.1371\/journal.pone.0208601","volume":"13","author":"C Betsch","year":"2018","unstructured":"Betsch\u00a0C, Schmid\u00a0P, Heinemeier\u00a0D, Korn\u00a0L, Holtmann\u00a0C, B\u00f6hm\u00a0R (2018) Beyond confidence: development of a\u00a0measure assessing the 5C psychological antecedents of vaccination. PLoS ONE 13:e208601. https:\/\/doi.org\/10.1371\/journal.pone.0208601","journal-title":"PLoS ONE"},{"key":"3716_CR43","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12877-017-0597-y","volume":"17","author":"J-O Bock","year":"2017","unstructured":"Bock\u00a0J\u2011O, Hajek\u00a0A, K\u00f6nig\u00a0H\u2011H (2017) Psychological determinants of influenza vaccination. BMC Geriatr 17:194. https:\/\/doi.org\/10.1186\/s12877-017-0597-y","journal-title":"BMC Geriatr"},{"key":"3716_CR44","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.ypmed.2008.08.001","volume":"47","author":"ZH Abramson","year":"2008","unstructured":"Abramson\u00a0ZH, Levi\u00a0O (2008) Is performance of influenza vaccination in the elderly related to treating physician\u2019s self immunization and other physician characteristics? Prev Med 47:550\u2013553. https:\/\/doi.org\/10.1016\/j.ypmed.2008.08.001","journal-title":"Prev Med"},{"key":"3716_CR45","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1001\/archinte.161.22.2702","volume":"161","author":"KL Nichol","year":"2001","unstructured":"Nichol\u00a0KL, Zimmerman\u00a0R (2001) Generalist and subspecialist physicians\u2019 knowledge, attitudes, and practices regarding influenza and pneumococcal vaccinations for elderly and other high-risk patients: a\u00a0nationwide survey. Arch Intern Med 161:2702\u20132708. https:\/\/doi.org\/10.1001\/archinte.161.22.2702","journal-title":"Arch Intern Med"},{"key":"3716_CR46","unstructured":"BARMER Institut f\u00fcr Gesundheitssystemforschung (2022) BARMER Morbidit\u00e4ts- und Sozialatlas. H\u00f6chste Krankheitslast in Th\u00fcringen. https:\/\/www.barmer.de\/resource\/blob\/1127250\/787de0286cfc98464b0053c9a206743a\/hoechste-krankheitslast-in-thueringen-bifg-data.jpg. Zugegriffen: 8. Aug. 2022"},{"key":"3716_CR47","doi-asserted-by":"publisher","DOI":"10.25646\/9044","author":"J Koch","year":"2021","unstructured":"Koch\u00a0J, Wichmann\u00a0O, Mertens\u00a0T (2021) STIKO-Empfehlung zur Koadministration von COVID-19-Impfstoffen und anderen Totimpfstoffen und die dazugeh\u00f6rige wissenschaftliche Begr\u00fcndung. Epidemiol Bull. https:\/\/doi.org\/10.25646\/9044","journal-title":"Epidemiol Bull"},{"key":"3716_CR48","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.vaccine.2021.11.097","volume":"40","author":"RP Lennon","year":"2022","unstructured":"Lennon\u00a0RP, Block\u00a0R, Schneider\u00a0EC, Zephrin\u00a0L, Shah\u00a0A (2022) Underserved population acceptance of combination influenza-COVID-19 booster vaccines. Vaccine 40:562\u2013567. https:\/\/doi.org\/10.1016\/j.vaccine.2021.11.097","journal-title":"Vaccine"},{"key":"3716_CR49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.25646\/9436","volume":"50","author":"T Rieck","year":"2021","unstructured":"Rieck\u00a0T, Steffen\u00a0A, Feig\u00a0M, Siedler\u00a0A (2021) Impfquoten bei Erwachsenen in Deutschland \u2013 Aktuelles aus der KV-Impfsurveillance. Epidemiol Bull 50:3\u201322. https:\/\/doi.org\/10.25646\/9436","journal-title":"Epidemiol Bull"},{"key":"3716_CR50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.25646\/10855","volume":"49","author":"T Rieck","year":"2022","unstructured":"Rieck\u00a0T, Steffen\u00a0A, Feig\u00a0M, Siedler\u00a0A (2022) Impfquoten bei Erwachsenen in Deutschland \u2013 Aktuelles aus der KV-Impfsurveillance. Epidemiol Bull 49:3\u201323. https:\/\/doi.org\/10.25646\/10855","journal-title":"Epidemiol Bull"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-023-03716-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00103-023-03716-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-023-03716-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T13:04:36Z","timestamp":1693314276000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00103-023-03716-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["3716"],"URL":"https:\/\/doi.org\/10.1007\/s00103-023-03716-1","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"type":"print","value":"1436-9990"},{"type":"electronic","value":"1437-1588"}],"subject":[],"published":{"date-parts":[[2023,6,8]]},"assertion":[{"value":"8 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.\u00a0Storch, F.\u00a0Meissner, M.\u00a0B\u00f6de, M.\u00a0W. Pletz und A.\u00a0Freytag geben an, dass kein Interessenkonflikt besteht. A.\u00a0Kwetkat erhielt Forschungsunterst\u00fctzung durch die Robert-Bosch-Stiftung, Forschungskolleg Geriatrie und Pfizer Pharma GmbH. Ferner erhielt sie Honorare f\u00fcr Beratungs\u2011\/Gutachtert\u00e4tigkeit von Seqirus, GlaxoSmithKline GmbH & Co. KG, Pfizer Pharma GmbH, Sanofi-Pasteur und Astra Zeneca sowie f\u00fcr Vortragst\u00e4tigkeit\/Manuskripterstellung von Pfizer Pharma GmbH, MSD, Fa. Novartis, Fa. Daiichi-Sankyo, Fa. Bristol-Myers Squibb und Fa. Sanofi-Pasteur.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autorinnen und Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}